Clinical Trial Update: Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

View source ↗

Summary

Clinical trial update for LipaCreon in pancreatic exocrine insufficiency due to cystic fibrosis has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Pancreatic Exocrine Insufficiency

Drugs mentioned

• LipaCreon

Snippet

Sponsor: Mylan Inc. | Conditions: Cystic Fibrosis, Exocrine Pancreatic Insufficiency | Status: COMPLETED | Results posted: 2022-06-10